Skip to content

Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction

The Clinical Utility of Urine Intestinal Fatty Acid Binding Protein in the Management of Very Low Birth Weight Infants With Meconium Obstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02864446
Enrollment
100
Registered
2016-08-12
Start date
2012-10-31
Completion date
2015-09-30
Last updated
2016-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meconium Obstruction of Prematurity

Brief summary

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 36 Weeks
Healthy volunteers
No

Inclusion criteria

* preterm infants weighing \<1,250g

Exclusion criteria

* major congenital anomalies * perinatal asphyxia (cord pH \<7.0)

Design outcomes

Primary

MeasureTime frame
Comparison of i-FABP level between the meconium obstruction group and the normal feeding advance groupwithin 48 hours after birth

Other

MeasureTime frame
Comparison of i-FABP level between breast milk feeding and formular feeding in the normal feeding advance groupthrough study completion (an average of 1 month)
Comparison of i-FABP level between preterm infants with small for gestational age and without small for gestational age in the normal feeding advance groupwithin 48 hours after birth
Comparision of i-FABP level between preterm infants with chorioamnionitis and without chorioamnionitis in the normal feeding advance groupwithin 48 hours after birth
Comparision of i-FABP level between preterm infants with maternal pregnancy induced hypertension (PIH) and without maternal PIH in the normal feeding advance groupwithin 48 hours after birth
Comparison of i-FABP level between preterm infants with maternal premature rupture of membrane (PROM) and without PROM in the normal feeding advance groupwithin 48 hours after birth

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026